Oruka Therapeutics (ORKA) PT Raised to $133 at Jefferies

April 27, 2026 7:54 AM

Jefferies analyst Roger Song raised the price target on Oruka Therapeutics (NASDAQ: ORKA) to $133.00 (from $107.00) while maintaining a Buy rating.

No results found